Mostrar el registro sencillo del ítem
dc.contributor.author | López Vázquez, Antonio | |
dc.contributor.author | Mozo, Lourdes | |
dc.contributor.author | Alonso Arias, Rebeca | |
dc.contributor.author | Suárez Álvarez, Beatriz | |
dc.contributor.author | Vidal Castiñeira, José Ramón | |
dc.contributor.author | Arranz Sanz, Eduardo | |
dc.contributor.author | Volta, Umberto | |
dc.contributor.author | Bousoño, Carlos | |
dc.contributor.author | López Hoyos, Marcos | |
dc.contributor.author | Rodrigo, Luis | |
dc.contributor.author | López Larrea, Carlos | |
dc.date.accessioned | 2020-08-24T08:55:09Z | |
dc.date.available | 2020-08-24T08:55:09Z | |
dc.date.issued | 2014 | |
dc.identifier.citation | BMC Medicine, 2014, volume 12, n. 1, Article number 34 | es |
dc.identifier.issn | 1741-7015 | es |
dc.identifier.uri | http://uvadoc.uva.es/handle/10324/41883 | |
dc.description | Producción Científica | es |
dc.description.abstract | Overexpression of autologous proteins can lead to the formation of autoantibodies and autoimmune diseases. MHC class I polypeptide-related sequence A (MICA) is highly expressed in the enterocytes of patients with celiac disease, which arises in response to gluten. The aim of this study was to investigate anti-MICA antibody formation in patients with celiac disease and its association with other autoimmune processes. | es |
dc.format.mimetype | application/pdf | es |
dc.language.iso | eng | es |
dc.publisher | Bio Med Central (BMC) | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject.classification | Anticuerpos | es |
dc.subject.classification | Enfermedad celíaca | es |
dc.title | Autoantibodies against MHC class I polypeptide-related sequence A are associated with increased risk of concomitant autoimmune diseases in celiac patients | es |
dc.type | info:eu-repo/semantics/article | es |
dc.rights.holder | © Bio Med Central | es |
dc.identifier.doi | 10.1186/1741-7015-12-34 | es |
dc.relation.publisherversion | https://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-12-34 | es |
dc.identifier.publicationissue | 1 | es |
dc.identifier.publicationtitle | BMC Medicine | es |
dc.identifier.publicationvolume | 12 | es |
dc.peerreviewed | SI | es |
dc.description.project | Instituto de Salud Carlos III, RETICS REDiNREN (RD12/0021/0021) | es |
dc.identifier.essn | 1741-7015 | es |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es |
dc.subject.unesco | 3205 Medicina Interna | es |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
La licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional